<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ashton L</submitter><funding>NCATS NIH HHS</funding><pagination>63-68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12826440</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>193</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the efficacy of a single injection of platelet-rich plasma (PRP) into the anterior vaginal wall at the mid-urethra compared to placebo, as there is emerging evidence that PRP may help treat female stress urinary incontinence (SUI).&lt;h4>Methods&lt;/h4>This was a single-blind, randomized, placebo-controlled clinical trial at a single institution. Females with bothersome, demonstrable stress-predominant urinary incontinence were enrolled. Participants were randomized to either injection of 5 mL autologous PRP or saline at the anterior vaginal wall at the mid-urethra. The primary outcome was composite treatment success at 6 months, defined as a negative cough stress test and an answer of "much better" or "very much better" on the Patient's Global Impression of Improv</pubmed_abstract><journal>Urology</journal><pubmed_title>A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial.</pubmed_title><pmcid>PMC12826440</pmcid><funding_grant_id>UM1 TR004403</funding_grant_id><pubmed_authors>Kruse R</pubmed_authors><pubmed_authors>Takacs EB</pubmed_authors><pubmed_authors>Vollstedt AJ</pubmed_authors><pubmed_authors>Kenne K</pubmed_authors><pubmed_authors>Wendt L</pubmed_authors><pubmed_authors>Johnson CM</pubmed_authors><pubmed_authors>Nakatsuka H</pubmed_authors><pubmed_authors>Kreder KJ</pubmed_authors><pubmed_authors>Ashton L</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial.</name><description>&lt;h4>Objective&lt;/h4>To determine the efficacy of a single injection of platelet-rich plasma (PRP) into the anterior vaginal wall at the mid-urethra compared to placebo, as there is emerging evidence that PRP may help treat female stress urinary incontinence (SUI).&lt;h4>Methods&lt;/h4>This was a single-blind, randomized, placebo-controlled clinical trial at a single institution. Females with bothersome, demonstrable stress-predominant urinary incontinence were enrolled. Participants were randomized to either injection of 5 mL autologous PRP or saline at the anterior vaginal wall at the mid-urethra. The primary outcome was composite treatment success at 6 months, defined as a negative cough stress test and an answer of "much better" or "very much better" on the Patient's Global Impression of Improv</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-06T22:01:09.934Z</modification><creation>2026-06-05T03:12:06.824Z</creation></dates><accession>S-EPMC12826440</accession><cross_references><pubmed>38942391</pubmed><doi>10.1016/j.urology.2024.06.047</doi></cross_references></HashMap>